Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025BloodOpen Access

Real-world treatment and outcomes of Mantle Cell Lymphoma in Latin America: A multinational cohort analysis

View Full Paper
Ask AI
Bookmark
Share

Authors

LRLuis Felipe RubalcavaBBBrady BeltránJMJosé Luis Álvarez Macías

Discussion

Loading...

Member takes

Overview

Retrospective cohort analysis highlights disparities in treatment and survival outcomes in Latin America for Mantle Cell Lymphoma patients, indicating urgent need for improved access to therapies.

Key Points

  • Overall survival at 36 months was 68.4% in patients with Mantle Cell Lymphoma from Latin America, revealing significant treatment disparities.
  • Median overall survival was 80.5 months; autologous stem cell transplantation significantly improved survival compared to non-transplanted patients.
  • This was a multicenter cohort study conducted across 19 institutions in 8 Latin American countries from 2015 to 2024.
  • Findings underscore the need for equitable access, treatment harmonization, and expansion of clinical trials across Latin America.

Cite This Study

Rubalcava et al. (2025) studied this question.

synapsesocial.com/papers/69362f514fa91c937236d9dchttps://doi.org/10.1182/blood-2025-3586
View Full Paper
Ask AI
Bookmark
Share